MCK - McKesson Corporation
579.74
| Index: | S&P 500 | P/E: | 30.05 | EPS (ttm): | 19.29 | Insider Own: | 0.11% | Shs Outstand: | 127.00M | Perf Week: | 0.61% |
| Market Cap: | 73.66B | Forward P/E: | 15.75 | EPS next Y: | 36.80 | Insider Trans: | -7.81% | Shs Float: | 126.80M | Perf Month: | -6.67% |
| Income(ttm): | 2.54B | PEG: | 2.18 | EPS next Q: | 8.24 | Inst Own: | 88.17% | Short Float: | 1.51% | Perf Quarter: | 14.80% |
| Revenue(ttm): | 330.19B | P/S: | 0.22 | EPS this Y: | 19.21% | Inst Trans: | -1.69% | Short Ratio: | 2.01 | Perf Half Y: | -4.62% |
| Book/sh: | -23.76 | P/B: | - | EPS next Y: | 12.52% | ROA: | 3.66% | Short Interest: | 1.91M | Perf Year: | 30.00% |
| Cash/sh: | 19.76 | P/C: | 29.33 | EPS next 5Y: | 13.77% | ROE: | - | 52W Range: | 445.06 - 637.51 | Perf YTD: | 25.22% |
| Dividend Est.: | 2.56 (0.44%) | P/FCF: | 16.01 | EPS past 5Y: | 164.60% | ROI: | 64.93% | 52W High: | -9.06% | Beta: | 0.52 |
| Dividend TTM: | 2.66 (0.46%) | Quick Ratio: | 0.50 | Sales past 5Y: | 7.64% | Gross Margin: | 3.82% | 52W Low: | 30.26% | ATR (14): | 12.54 |
| Dividend Ex-Date: | Dec 02, 2024 | Current Ratio: | 0.91 | EPS Y/Y TTM: | -23.80% | Oper. Margin: | 1.15% | RSI (14): | 46.57 | Volatility: | 2.62% 1.91% |
| Employees: | 51000 | Debt/Eq: | - | Sales Y/Y TTM: | 13.43% | Profit Margin: | 0.77% | Recom: | 1.58 | Target Price: | 671.79 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | - | EPS Q/Q: | -62.16% | Payout: | 10.72% | Rel Volume: | 2.16 | Prev Close: | 579.22 |
| Sales Surprise: | 4.84% | EPS Surprise: | 2.75% | Sales Q/Q: | 21.29% | Earnings: | Nov 06 AMC | Avg Volume: | 951.25K | Price: | 579.74 |
| SMA20: | -3.00% | SMA50: | 1.89% | SMA200: | 4.39% | Undervalued: 15.88% | Volume: | 2,057,106 | Change: | 0.09% | |
Graham Classic formula value: 624.27
(P/E=8 * 1g) Min value: 377.09
(current P/E * 2g) Max value: 997.55
Average value: 666.3
McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.